Back

Mortality and cause of death in patients undergoing mitral valve surgery for mitral regurgitation: a nationwide cohort study

31 August 2025 (12:10 - 12:20)
Organised by: Logo
Congress Presentation Part of: Trends from valve surgery to intervention Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Kamillia Baker

Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Impact of mitral valve repair on global and regional longitudinal strain in patients with fibroelastic deficiency versus Barlow's disease
Mr C. Berg-Hansen (Bergen, NO)
Abstract Slides Video
Presentation thumbnail
Trends in tricuspid valve interventions and surgery in Germany from 2018 to 2023
Doctor I. Mattig (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Temporal trends in the management of aortic stenosis in Sweden; a nationwide study
Doctor K. Nilsson (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Clinical presentation and outcomes after surgery for mitral regurgitation - Real world insights from the MITRACURE international registry
Professor D. Messika Zeitoun (Ottawa, CA)
Abstract Slides Video
Presentation thumbnail
Is myocardial adaptation distinct in patients with bicuspid versus tricuspid severe aortic stenosis undergoing surgical valve replacement?
Doctor D. Da Silva Correia (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Trends from valve surgery to intervention
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 12:10 CET
You may be interested in
thumbnail
Congress Session
Registries on valvular heart disease
thumbnail
Congress Presentation
Mitral valve reoperation versus first-time surgery for mitral regurgitation: comparison of patient characteristics, type of surgery and mortality in a nationwide cohort
thumbnail
Congress Session
Trends from valve surgery to intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources